Literature DB >> 12966785

[Acute pancreatitis].

S Wagner1, H Lübbers, R Mahlke, C H Müller, P G Lankisch.   

Abstract

While interstitial acute pancreatitis usually takes a benign course, necrotizing acute pancreatitis takes a severe course, mainly because of severe local and systemic complications. After a quick diagnosis it is necessary to rapidly assess a degree of severity of the disease and thus the prognosis. The clinical picture and the result of imaging procedures do not always correspond. The management basically includes to treat pain as well as to administer fluid, electrolyte, protein and calories. In addition, systemic treatment of complications such as shock or respiratory and renal insufficiency--if occurring--is necessary. In case of pancreatic necrosis, prophylactic administration of pancreas-penetrable antibiotics is recommended to avoid infection. In the severely ill with infected pancreatic necrosis, surgery is the treatment of choice. In approximately 10% of all patients with alcohol-induced pancreatitis, there is a gradual transition to chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966785     DOI: 10.1007/s00108-003-0910-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  87 in total

1.  The APACHE II score is unreliable to diagnose necrotizing pancreatitis on admission to hospital.

Authors:  Paul Georg Lankisch; Bettina Warnecke; Dirk Bruns; Hans-Martin Werner; Franziska Grossmann; Karl Struckmann; Gisbert Brinkmann; Patrick Maisonneuve; Albert B Lowenfels
Journal:  Pancreas       Date:  2002-04       Impact factor: 3.327

2.  Relationship of necrosis to organ failure in severe acute pancreatitis.

Authors:  S Tenner; G Sica; M Hughes; E Noordhoek; S Feng; M Zinner; P A Banks
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

3.  Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results.

Authors:  P C Freeny; E Hauptmann; S J Althaus; L W Traverso; M Sinanan
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

4.  Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis.

Authors:  E J Luiten; W C Hop; J F Lange; H A Bruining
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

5.  No parallel between the biochemical course of acute pancreatitis and morphologic findings.

Authors:  P G Lankisch; M Haseloff; R Becher
Journal:  Pancreas       Date:  1994-03       Impact factor: 3.327

6.  Acute pancreatitis: value of CT in establishing prognosis.

Authors:  E J Balthazar; D L Robinson; A J Megibow; J H Ranson
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

7.  Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group.

Authors:  M Büchler; P Malfertheiner; W Uhl; J Schölmerich; F Stöckmann; G Adler; W Gaus; K Rolle; H G Beger
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

8.  Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis.

Authors:  C Bassi; M Falconi; G Talamini; G Uomo; G Papaccio; C Dervenis; R Salvia; E B Minelli; P Pederzoli
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

9.  Early antibiotic treatment in acute necrotising pancreatitis.

Authors:  V Sainio; E Kemppainen; P Puolakkainen; M Taavitsainen; L Kivisaari; V Valtonen; R Haapiainen; T Schröder; E Kivilaakso
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

10.  Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis.

Authors:  C Y Yang; C S Chang-Chien; Y F Liaw
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

View more
  1 in total

1.  [Acute pancreatitis].

Authors:  N Teich; S Leinung; S Jonas; J Mössner
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.